ArticleEuropean journal of clinical pharmacology2025

A real-world pharmacovigilance study of FDA Adverse Event Reporting System events for gefitinib and docetaxel.

Chengqian Cui et al.PubMed ↗Publisher ↗

No numbers read from the abstract.